Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002048 · ClinicalTrials.gov registry record · NA

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

A NA study of HIV Infections and Lymphatic Disease, sponsored by Glaxo Wellcome.

Completed
Registry status
NA
Development phase
20
Study locations

NCT00002048 is a NA study of HIV Infections and Lymphatic Disease that has completed, run by Glaxo Wellcome. The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002048, a NA study of HIV Infections and Lymphatic Disease, has completed, sponsored by Glaxo Wellcome.

COMPLETED
Registry status
NA
Development phase
20
Study locations

Study Summary

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) in HIV-infected adult patients without clinical manifestations of disease. To assess the efficacy of AZT therapy in the treatment of HIV disease in these patients.

Conditions Studied

HIV Infections Lymphatic Disease

Interventions

  • DRUG Zidovudine

Study Locations (20)

California

  • LaJolla Veterans Administration Med Ctr - La Jolla
  • AIDS Clinical Trials Group - San Diego

Florida

  • Univ of Miami School of Medicine - Miami
  • Univ of South Florida - Tampa

North Carolina

  • Nalle Clinic - Charlotte
  • Bowman Gray School of Medicine / North Carolina Baptist Hosp - Winston-Salem

Oregon

  • Oregon Health Sciences Univ - Portland
  • Good Samaritan Hosp - Portland

Pennsylvania

  • Buckley Braffman Stern Med Associates - Philadelphia
  • Graduate Hosp - Philadelphia

Texas

  • Univ TX Galveston Med Branch - Galveston
  • Baylor College of Medicine - Houston

Utah

  • Dr Kristen Reis - Salt Lake City
  • Univ of Utah School of Medicine - Salt Lake City

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.

Trial Details

FieldValue
Phase NA

Sponsor

Glaxo Wellcome

65 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002048

The ClinicalTrials.gov registry entry for NCT00002048 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Glaxo Wellcome, which has 65 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Zidovudine is the first listed.

NCT00002048 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00002048 about?

NCT00002048 is a clinical study titled "The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)". To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) in HIV-infected adult patients without clinical manifestations of disease. To assess the efficacy of AZT therapy in the treatment of HIV disease in these patients.

What is the current status of trial NCT00002048?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002048 study?

This clinical trial studies the following conditions: HIV Infections, Lymphatic Disease.

What interventions are being tested in trial NCT00002048?

The interventions under investigation include: Zidovudine (DRUG).

Who is sponsoring clinical trial NCT00002048?

This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002048 being conducted?

This trial has 20 study locations across California, District of Columbia, Florida, Georgia, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Lymphatic Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.